NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 5, 2026
$23,20
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$21,02rendah 52m
$42,21tinggi 52m
Kapitalisasi Pasar (MRQ)
$2.73B
lencana Anda
Rentang 52M
$21–$42
Peringkat Analis
BUY
Target Harga
$50
P/E
·
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
NAMS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$23.20
Kapitalisasi Pasar (MRQ)
$2.73B
Rentang 52M
$21–$42
NAMS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | NAMS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/B (MRQ) | 4.3 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | NAMS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 9.0 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.5%
Laporan Berikutnya
Nov 03, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 12, 2026 | $-0.52 | $-0.50 | -4.4% |
| 31 Maret 2026 | Mei 7, 2026 | $-0.40 | $-0.50 | 20.3% |
| 31 Des. 2025 | $-0.62 | $-0.39 | -57.8% | |
| 30 Sep. 2025 | $-0.61 | $-0.40 | -51.0% | |
| 30 Juni 2025 | $-0.15 | $-0.50 | 70.1% | |
| 31 Maret 2025 | $-0.34 | $-0.50 | 31.7% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $490M | |
| Short-term Investments | $146M | |
| Prepaid Expense | $38M | |
| Current Assets | $676M | |
| PP&E (Net) | $383.0K | |
| Total Assets | $769M | |
| Accounts Payable | $9M | |
| Current Liabilities | $86M | |
| Capital Leases | $66.0K | |
| Total Liabilities | $86M | |
| Common Stock | $14M | |
| Retained Earnings | $-762M | |
| AOCI | $5M | |
| Stockholders' Equity | $683M | |
| Liabilities + Equity | $769M | |
| Shares Outstanding | 114,399,326 |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Revenue | $4M | $3M | |
| R&D Expense | $42M | $38M | |
| SG&A Expense | $27M | $23M | |
| Operating Expenses | $69M | $61M | |
| Operating Income | $-65M | $-58M | |
| Interest Income | $6M | $6M | |
| Pretax Income | $-64M | $-48M | |
| Net Income | $-64M | $-48M | |
| EPS (Basic) | $-0.52 | $-0.40 | |
| EPS (Diluted) | $-0.52 | $-0.40 | |
| Shares (Basic) | 123,370,232 | 121,716,006 | |
| Shares (Diluted) | 123,370,232 | 121,716,006 | |
| EBITDA | $-65M | $-58M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & Equivalents | $424M | $458M | |
| Short-term Investments | $210M | $178M | |
| Prepaid Expense | $24M | $21M | |
| Current Assets | $659M | $658M | |
| PP&E (Net) | $411.0K | $379.0K | |
| Total Assets | $704M | $733M | |
| Accounts Payable | $5M | $8M | |
| Current Liabilities | $73M | $67M | |
| Capital Leases | $56.0K | · | |
| Total Liabilities | $73M | $67M | |
| Common Stock | $15M | $15M | |
| Retained Earnings | $-875M | $-811M | |
| AOCI | $4M | $4M | |
| Stockholders' Equity | $631M | $665M | |
| Liabilities + Equity | $704M | $733M | |
| Shares Outstanding | 117,651,697 | 116,641,656 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| D&A | $59.0K | $62.0K | |
| Stock-based Comp | $18M | $18M | |
| Other Non-cash | · | $-227.0K | |
| Operating Cash Flow | $-39M | $-31M | |
| CapEx | $80.0K | $38.0K | |
| Investing Cash Flow | $-5M | $-12M | |
| Financing Cash Flow | $11M | $11M | |
| Free Cash Flow | · | $-31M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Operating Margin | -1752.6% | -1921.7% | |
| Net Margin | -1732.9% | -1593.5% | |
| Pretax Margin | -1732.9% | -1593.5% | |
| EBITDA Margin | -1752.6% | -1919.7% | |
| ROA | -8.4% | -6.2% | |
| ROE | -9.1% | -6.7% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Current Ratio | 9.0 | 9.8 | |
| Quick Ratio | 8.7 | 9.4 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Book Value / Share | $5.37 | $5.70 | |
| Revenue / Share | $0.03 | $0.03 | |
| Cash Flow / Share | · | $-0.25 | |
| Cash / Share | $3.61 | $3.92 | |
| EPS (TTM) | $-2.15 | $-1.78 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Revenue TTM | $7M | $23M | |
| Net Income TTM | $-260M | $-213M | |
| Market Cap | $3.99B | $3.73B | |
| P/E | -15.8 | -18.0 | |
| P/S | 559.9 | 165.5 | |
| P/B | 6.3 | 5.6 | |
| P / Tangible Book | 6.3 | 5.6 | |
| P / Cash Flow | · | -122.0 | |
| Earnings Yield | -6.3% | -5.6% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 217 pengaju · $4.0B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
217
Nilai yang dipegang
$4.0B
Posisi baru
53
Posisi yang keluar
17
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 53 (+27 vs Kuartal sebelumnya) | 17 (-20 vs Kuartal sebelumnya) | 74 (+7 vs Kuartal sebelumnya) | 50 (-2 vs Kuartal sebelumnya) | -2.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $613.032.889 | 18.088.902 | 15,23% | Saham |
| Capital World Investors | $414.493.577 | 12.230.557 | 10,30% | Saham |
| FMR LLC | $350.411.179 | 10.339.663 | 8,70% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $323.655.973 | 9.550.191 | 8,04% | Saham |
| FCPM III SERVICES B.V. | $287.738.063 | 8.490.353 | 7,15% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $144.533.699 | 4.264.789 | 3,59% | Saham |
| VIKING GLOBAL INVESTORS LP | $142.458.886 | 4.203.567 | 3,54% | Saham |
| Bain Capital Life Sciences Investors, LLC | $129.004.522 | 3.806.566 | 3,20% | Saham |
| MAVERICK CAPITAL LTD | $110.745.810 | 3.267.802 | 2,75% | Saham |
| Medicxi Ventures Management (Jersey) Ltd | $74.850.776 | 2.208.639 | 1,86% | Saham |
| JANUS HENDERSON GROUP PLC | $72.253.603 | 2.258.984 | 1,79% | Saham |
| JENNISON ASSOCIATES LLC | $71.246.471 | 2.102.286 | 1,77% | Saham |
| Orbis Allan Gray Ltd | $59.227.079 | 1.747.627 | 1,47% | Saham |
| Polar Capital Holdings Plc | $58.443.915 | 1.724.518 | 1,45% | Saham |
| Capital International Investors | $58.409.246 | 1.723.495 | 1,45% | Saham |
| GOLDMAN SACHS GROUP INC | $52.357.034 | 1.544.911 | 1,30% | Saham |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $52.071.036 | 1.536.472 | 1,29% | Saham |
| Castle Hook Partners LP | $46.463.359 | 1.371.005 | 1,15% | Saham |
| AMERIPRISE FINANCIAL INC | $42.482.886 | 1.253.549 | 1,06% | Saham |
| ALLIANCEBERNSTEIN L.P. | $40.330.679 | 1.259.940 | 1,00% | Saham |
| JPMORGAN CHASE & CO | $38.373.185 | 1.132.955 | 0,95% | Saham |
| Aberdeen Group plc | $37.373.384 | 1.102.785 | 0,93% | Saham |
| BlackRock, Inc. | $36.050.487 | 1.063.750 | 0,90% | Saham |
| FRANKLIN RESOURCES INC | $33.683.835 | 993.917 | 0,84% | Saham |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $26.472.835 | 781.140 | 0,66% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25.564.142 | 754.327 | 0,63% | Saham |
| Woodline Partners LP | $25.501.852 | 752.489 | 0,63% | Saham |
| BANK OF AMERICA CORP /DE/ | $24.925.518 | 735.483 | 0,62% | Saham |
| TimesSquare Capital Management, LLC | $24.071.136 | 751.988 | 0,60% | Saham |
| AMERICAN CENTURY COMPANIES INC | $23.208.343 | 684.813 | 0,58% | Saham |
| CITADEL ADVISORS LLC | $21.886.331 | 645.805 | 0,54% | Saham |
| Jefferies Financial Group Inc. | $20.334.000 | 600.000 | 0,51% | Opsi jual |
| Rock Springs Capital Management LP | $19.749.194 | 582.744 | 0,49% | Saham |
| First Turn Management, LLC | $19.740.823 | 582.497 | 0,49% | Saham |
| MORGAN STANLEY | $19.514.724 | 575.825 | 0,48% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.269.854 | 568.600 | 0,48% | Opsi jual |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18.639.500 | 550.000 | 0,46% | Saham |
| Artia Global Partners LP | $17.078.391 | 503.936 | 0,42% | Saham |
| MILLENNIUM MANAGEMENT LLC | $16.999.698 | 501.614 | 0,42% | Saham |
| PERCEPTIVE ADVISORS LLC | $16.945.000 | 500.000 | 0,42% | Opsi jual |
| Cormorant Asset Management, LP | $16.945.000 | 500.000 | 0,42% | Saham |
| JANE STREET GROUP, LLC | $16.071.858 | 474.236 | 0,40% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $14.280.365 | 421.374 | 0,35% | Saham |
| Bank of New York Mellon Corp | $11.973.270 | 353.298 | 0,30% | Saham |
| UBS Group AG | $11.660.363 | 344.065 | 0,29% | Saham |
| Slate Path Capital LP | $10.810.910 | 319.000 | 0,27% | Saham |
| ExodusPoint Capital Management, LP | $10.313.879 | 304.334 | 0,26% | Saham |
| Eversept Partners, LP | $9.335.712 | 275.471 | 0,23% | Saham |
| Affinity Asset Advisors, LLC | $9.319.750 | 275.000 | 0,23% | Saham |
| SEB Asset Management AB | $9.240.226 | 272.654 | 0,23% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| BCLS Fund III Investments, LP, Bain Capital Life Sciences Opportunities III, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCLS II Equity Opportunities, LP, BCIP Life Sciences Associates, LP ×6 pengajuan | 4 Des. 2025 | 4,70% | Amandemen | · | SEC |
| Frazier Life Sciences X, L.P., Frazier Lifesciences Sponsor LLC, FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×2 pengajuan | 4 Nov. 2025 | 7,70% | Amandemen | · | SEC |
| Forbion Capital Fund IV Cooperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Cooperatief U.A., Forbion Growth Management B.V., ForGrowth NAP B.V. ×2 pengajuan | 30 Sep. 2025 | 8,30% | Amandemen | · | SEC |
| Forbion Capital Fund IV Coöperatief U.A., Forbion IV Management B.V., Forbion Growth Opportunities Fund I Coöperatief U.A., Forbion Growth Management B.V., ForGrowth NAP B.V. ×4 pengajuan | 17 Des. 2024 | · | Pengajuan awal | · | SEC |
| Frazier Lifesciences Sponsor LLC, Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×5 pengajuan | 17 Des. 2024 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 15 orang dalam · 8 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Michael H. Davidson | Chief Executive Officer | 2 Maret 2026 M | 174.144 | 0 | 8 | $-25.328.350 |
| Mayur Ian Somaiya | Chief Financial Officer | 21 Jan. 2026 M | 58.382 | 0 | 6 | $-3.430.793 |
| Douglas F Kling | Chief Operating Officer | 16 Juli 2025 M | 44.000 | 0 | 0 | $0 |
| Louise Frederika Kooij | Chief Accounting Officer | 26 Mei 2026 M | 24.353 | 0 | 11 | $-12.356.307 |
| Johannes Jacob Pieter Kastelein | Chief Scientific Officer | 9 Maret 2026 M | 69.302 | 0 | 6 | $-10.896.367 |
| Michael F Marino III | Chief Legal Officer and Corporate Secretary | 1 Juni 2025 A | 55.000 | 0 | 0 | $0 |
| Juliette Berangere Audet | Chief Strategy and Business Officer | 1 Mei 2025 A | 15.104 | 0 | 0 | $0 |
| William A Jones JR | Chief Commercial Officer | 7 Jan. 2025 A | 43.000 | 0 | 0 | $0 |
| Louis G Lange | Direktur | 11 Maret 2026 S | 10.360 | 0 | 3 | $-2.186.180 |
| Hilde Johanna Van Der Kamp | Direktur | 7 Jan. 2026 A | 10.360 | 0 | 0 | $0 |
| Mark C. Mckenna | Direktur | 7 Jan. 2026 A | 10.360 | 0 | 0 | $0 |
| Adele M. Gulfo | Direktur | 7 Jan. 2026 A | 14.260 | 0 | 0 | $0 |
| John W Smither | Direktur | 7 Jan. 2026 A | 10.360 | 0 | 0 | $0 |
| William Lewis | Direktur | 7 Jan. 2026 A | 10.360 | 0 | 0 | $0 |
| James N. Topper | · | 15 Sep. 2025 P | 3.028.524 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 6 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| GURU · Global X Funds | 0,89% | 19.545 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 8.467 SH | 1 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,13% | 612.706 SH | 11 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,04% | 51.311 SH | 11 Sep. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,03% | 181.674 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 3.733 SH | 11 Sep. 2026 | Harian |
NAMS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 23 analis
BELI
Target median
$50.57
+118,0%
9 39,1%
Beli Kuat
12 52,2%
Beli
2 8,7%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
15 analis · 2026-10-01Target rata-rata $50.48 +117,6%
← Di bawah semua target
Harga saat ini $23.20
Rendah$37.15
Rata-rata$50.48
Tinggi$59.77
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 5, 2026